Advantage Austria Show navigation

Austrian Greiner Bio-One becomes main shareholder of Vigmed Holding AB

2. June 2017

Austrian investment drives safety standards for medical devices

Greiner Bio-One (GBO) well known in the area of biotechnology and medical devices announces its cooperation with the Swedish Vigmed Holding AB . Vingmed focuses on the development of high safety catheter solutions. The Austrian company could prevail against other investors. A significant majority of Vigmed’s shareholders accepted the attractive offer and the settlement was already initiated on the 25th May 2017.

Vigmed benefits from the investment as they can now realize their long-term strategy to become the leading innovator to eliminate needle stick injuries within the healthcare sector till 2020 and to exploit all its full potential. Through GBO's stable financial position, its strong brand and market position, Vigmed can leverage on GBO's global sales and distribution network and expand its global footprint in an efficient way", said Rainer Perneker, CEO of the Greiner Bio-One group.

Last modified
2. June 2017
print
©©ADVANTAGE AUSTRIA